Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion type Assertion NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_head.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion description "[The unexpected finding of an antibody that can activate FGF21-like signaling through cell surface receptors provided preclinical validation for an innovative therapeutic approach to diabetes and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion evidence source_evidence_literature NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion SIO_000772 23197570 NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion wasDerivedFrom befree-20150227 NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.
- NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_assertion wasGeneratedBy ECO_0000203 NP882974.RAeLOckvKwKH8OYpieutX54WmJdgrYg6bj3clMf1yJeek130_provenance.